NEWPORT BEACH, CA -- Scienza Health today announced a fundamental shift in how GIA, the company’s FDA-registered Digital Human, generates clinical responses. GIA has crossed from probabilistic AI to deterministic AI. Every response she delivers is now benchmarked in real time against a de-identified longitudinal dataset of 27 billion clinical events and 3 million neurodegenerative patient journeys -- grounding her outputs in what actually happened to matched patients, not in what a language model predicts.
Until now, every clinical AI system -- including GIA -- reasoned from training data. Responses were informed by patterns learned during model development. They were educated estimates. With this breakthrough, GIA no longer generates estimates from training data alone. When a patient speaks to GIA, their clinical profile is matched in real time against one of the largest de-identified longitudinal cognitive care datasets ever assembled for post-acute and long-term care. GIA surfaces what interventions worked for patients with the same profile, what their trajectory looked like, and what the care team should do next -- before the clinician opens the chart.
GIA does not ask patients to answer questionnaires or self-report symptoms. She listens. During every session GIA’s speech biomarker engine analyzes 2,500+ acoustic and linguistic signals -- pause ratio, speech rate, vocal energy, pitch variability, semantic coherence, and word-finding patterns -- that are clinically associated with cognitive decline, depression, anxiety, Parkinson’s disease, and 42 other conditions. That output is matched in real time against the longitudinal dataset. The result is a clinical response grounded in evidence from matched patients, not a prediction generated from training data.
“There is a fundamental difference between a system that reasons from what it learned during training and one that grounds its responses in what actually happened to 3 million real patients,” said David Kaiser, CEO and co-founder of Scienza Health. “GIA used to reason. Now she knows. We crossed that line this week.”
Proactive Decline Orchestrators
The breakthrough is powered by PDO -- Proactive Decline Orchestrators -- a longitudinal clinical intelligence engine developed by Scienza Health. PDO automatically ingests GIA’s speech biomarker output alongside wearable signals from [Samsung Health Grade Galaxy](/press/samsung-galaxy-partnership-2025) devices and clinical chart data from integrated EHR systems. It queries the longitudinal dataset in real time, returning a matched cohort, a decline probability with a predicted horizon, and a ranked care plan grounded in real outcome evidence.
- Cognitive decline: early trajectory detection benchmarked against 3 million neurodegenerative patient journeys
- Agitation and behavioral events: pattern recognition grounded in longitudinal behavioral data across post-acute and long-term care populations
- Fall risk: multimodal signal fusion from speech biomarkers, wearable data, and clinical chart history
- Infection onset: predictive flagging calibrated against real readmission outcome data for Enhanced Track ACOs
Clinical Intelligence That Compounds
Every session builds longitudinal memory. The first time GIA speaks with a patient she captures a baseline. By the second session she can compare. By the third she is tracking a trajectory. The clinical intelligence compounds with every conversation and every facility.
- FDA-registered: GIA is HIPAA compliant and deployed on Samsung Health Grade Galaxy devices secured by Samsung Knox
- 46 conditions: GIA screens for 46 cognitive, behavioral, and neurological conditions from a single conversation in under five minutes, with results in 60 seconds
- EHR integration: GIA is integrated with [PointClickCare](/press/pointclickcare-marketplace-2026), Epic, Cerner, and MatrixCare, giving her access to a network of 26,000 post-acute and long-term care facilities
- Clinician review: GIA screens -- she does not diagnose. A clinician reviews and approves every result before it enters the clinical record
“Six million Americans are living with dementia today. Every one of them deserves a care team that knows what is coming before it arrives. That is what GIA does now.”
— David Kaiser, CEO and co-founder, Scienza Health
For Enhanced Track ACOs -- which write a check back to CMS when they miss readmission benchmarks -- GIA’s deterministic outputs function as financial risk infrastructure, not a screening tool.
Contact: david@scienzahealth.com | scienzahealth.com Note to editors: GIA screens. She does not diagnose. All GIA outputs are reviewed and approved by a licensed clinician before entering the clinical record.
About Scienza Health
Scienza Health builds digitalhumanOS™ and GIA® — the world’s first cleared digital human and clinical AI operating system purpose-built for post-acute and long-term care. GIA® screens for 46 clinical conditions using Voice AI, Computer Vision, and Speech Biomarkers in a single patient conversation lasting under five minutes. The platform is powered by 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events. FDA-registered. HIPAA compliant. Bundled on Samsung Health Grade Galaxy devices. Headquartered in Newport Beach, California.
Note to editors: digitalhumanOS™ and GIA® are trademarks of Scienza Health, Inc. All other trademarks are the property of their respective owners.
Related Press Releases
62 Million American Employees Live With Mental Illness. 46 Percent Receive No Treatment. Scienza Health’s GIA Now Screens for Depression, Anxiety, and PTSD in 40 Seconds.
LeadershipScienza Health Reports 14,600+ Facility Reach Following PointClickCare Marketplace Launch at HIMSS 2026
PartnershipScienza Health’s GIA® Now Live in the PointClickCare Marketplace
See GIA® screen a patient live
46 conditions. Under 5 minutes. 60-second results. Zero staff time during screening.
Schedule a Demo